Suppr超能文献

[基于临床病理特征和分子特征的三种不同部位结直肠癌的差异]

[The differences between three distinct locations of colorectal cancers based on clinicopathological characteristics and molecular features].

作者信息

Li Cong, Wang Zhimin, Zhao Jiang, Cai Sanjun, Xu Ye, Liu Fangqi

机构信息

Department of Colorectal Surgery, Fudan University Shanghai Cancer Center (Department of Oncology, Shanghai Medical College, Fudan University), Shanghai 200032, China.

Email:

出版信息

Zhonghua Yu Fang Yi Xue Za Zhi. 2014 Dec;48(12):1078-82.

Abstract

OBJECTIVE

To investigate the differences of clinical characteristics and molecular features among colorectal cancer subsides and provide evidence for colorectal cancer protection, diagnosis and treatment.

METHODS

All of 4 316 colorectal patients from Shanghai cancer center were selected for clinical character analysis, among which, 2 224 subjects for molecular feature analysis. Clinic pathological characteristics like age, gender, tumor types, histological types, differentiation and T-stage, as well as molecular features like hMLH1, hMSH2, CD44, p21, p53, COX2,E-cadherin, Her2 and Ki-67, were involved into this research.

RESULTS

It showed that compared with left-sided colon and rectal cancers, right-sided cancers occurred more in women (46.0% (541/1 176); 39.2% (424/1 083); 41.2% (848/2 057), respectively, χ² = 11.85, P < 0.01), had more mucinous or signet-ring carcinoma (12.0% (128/1 064), 5.8% (56/960), 4.0% (75/1 859), respectively, χ² = 31.27, P < 0.01), poor differentiated carcinoma (32.1% (343/1 069), 19.5% (201/1 033), 19.3% (380/1 967), respectively, χ² = 72.66, P < 0.01) , and advanced T stage (87.9% (992/1 129), 83.2% (869/1 045), 72.2% (1 486/2 057), respectively, χ² = 121.44, P < 0.01). Meanwhile, the rates of hMLH1 were higher in right-sided colon cancers when compared with rectal cancers (13.4% (59/439) vs 8.5% (88/1 035), OR (95%CI): 1.67 (1.18-2.37)), as well as the rates of hMSH2 negative expression (4.9% (22/452) vs 2.4% (26/1 083), OR (95% CI): 2.08(1.17-3.71)). The rates of p53 positive expression were higher in right-sided colon cancers when compared with rectal cancers (76.2% (321/421) vs 68.4%, (776/1 134), OR (95% CI): 0.68 (0.52-0.87)). Compared with right-sided colon cancers, the rates of Her2 positive expression were higher in rectal cancers (19.3% (176/913) vs 13.2% (45/340), OR (95% CI): 1.57 (1.10-2.23)) , as well as the rates of Ki-67 expression which was positive in more than 50% cells (73.6% (840/1 141) vs 65.6% (299/456), OR (95% CI): 0.68 (0.54-0.86)).

CONCLUSION

There are specific characteristics in right-sided colon cancers. The difference of molecular features between right-sided colon and rectal cancers are more significant.

摘要

目的

探讨结直肠癌不同部位的临床特征及分子特征差异,为结直肠癌的防治及诊疗提供依据。

方法

选取上海癌症中心4316例结直肠癌患者进行临床特征分析,其中2224例进行分子特征分析。研究内容包括年龄、性别、肿瘤部位、组织学类型、分化程度、T分期等临床病理特征,以及hMLH1、hMSH2、CD44、p21、p53、COX2、E-钙黏蛋白、Her2和Ki-67等分子特征。

结果

结果显示,与左半结肠癌和直肠癌相比,右半结肠癌女性发病率更高(分别为46.0%(541/1176)、39.2%(424/1083)、41.2%(848/2057),χ² = 11.85,P < 0.01),黏液腺癌或印戒细胞癌更多见(分别为12.0%(128/1064)、5.8%(56/960)、4.0%(75/1859),χ² = 31.27,P < 0.01),低分化癌更多(分别为32.1%(343/1069)、19.5%(201/1033)、19.3%(380/1967),χ² = 72.66,P < 0.01),T分期更晚(分别为87.9%(992/1129)、83.2%(869/1045)、72.2%(1486/2057),χ² = 121.44,P < 0.01)。同时,右半结肠癌hMLH1表达率高于直肠癌(13.4%(59/439)对8.5%(88/1035),OR(95%CI):1.67(1.18 - 2.37)),hMSH2阴性表达率也更高(4.9%(22/452)对2.4%(26/1083),OR(95%CI):2.08(1.17 - 3.71))。右半结肠癌p53阳性表达率高于直肠癌(76.2%(321/421)对68.4%(776/1134),OR(95%CI):0.68(0.52 - 0.87))。与右半结肠癌相比,直肠癌Her2阳性表达率更高(19.3%(176/913)对13.2%(45/340),OR(95%CI):

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验